Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: Lower rates for 5 years post chemotherapy
-
Published:2024-09
Issue:9
Volume:26
Page:101172
-
ISSN:1098-3600
-
Container-title:Genetics in Medicine
-
language:en
-
Short-container-title:Genetics in Medicine
Author:
Evans D. GarethORCID,
Morgan Robert D.,
Crosbie Emma J.,
Howell Sacha J.,
Forde Claire,
Howell Anthony,
Lalloo Fiona,
Woodward Emma R.
Funder
University of Manchester